Wiley Interdiscip Rev Nanomed Nanobiotechnol
2015[Mar]; 7
(2
): 169-88
PMID25377691
show ga
Preclinical research in the field of nanomedicine continues to produce a steady
stream of new nanoparticles with unique capabilities and complex properties. With
improvements come promising treatments for diseases, with the ultimate goal of
clinical translation and better patient outcomes compared with current standards
of care. Here, we outline engineering considerations for nanomedicines, with
respect to design criteria, targeting, and stimuli-triggered drug release
strategies. General properties, clinical relevance, and current research advances
of various nanomedicines are discussed in light of how these will realize their
potential and shape the future of the field.
free
free
free
